John Evans
CEO
Head of Investor Relations
CEO
Board Member
Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Beam Therapeutics Inc. (BEAM) | CEO | $755,000 | $5,818,525 |
| 2024 | Beam Therapeutics Inc. (BEAM) | CEO | $715,750 | $6,409,631 |
| 2023 | Beam Therapeutics Inc. (BEAM) | CEO | $685,000 | $6,280,099 |
| 2022 | Beam Therapeutics Inc. (BEAM) | CEO | $650,000 | $9,496,745 |
| 2021 | Beam Therapeutics Inc. (BEAM) | CEO | $590,105 | $13,911,975 |
| 2020 | Beam Therapeutics Inc. (BEAM) | CEO | $529,271 | $906,768 |
| 2019 | Beam Therapeutics Inc. (BEAM) | CEO | $472,500 | $2,209,800 |
Executive changes
Earnings-call appearances
-
Beam Therapeutics Inc. Q4 FY2025 Earnings Call2026-02-24
Beam Therapeutics Inc. (BEAM)
-
Beam Therapeutics Inc. Q3 FY2024 Earnings Call2024-11-05
Beam Therapeutics Inc. (BEAM)
-
GrowGeneration Corp. Q3 FY2021 Earnings Call2021-09-30
GrowGeneration Corp. (GRWG)
-
GrowGeneration Corp. Q2 FY2021 Earnings Call2021-06-30
GrowGeneration Corp. (GRWG)
-
Brainstorm Cell Therapeutics Inc. Q3 FY2020 Earnings Call2020-10-15
Brainstorm Cell Therapeutics Inc. (BCLI)
-
Brainstorm Cell Therapeutics Inc. Q2 FY2020 Earnings Call2020-06-30
Brainstorm Cell Therapeutics Inc. (BCLI)